Skip to Main Content

Pulmatrix, Inc. Common Stock

PULM Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
PULM Income Statement
PULM Balance Sheet
PULM Cash Flow

Recent trades of PULM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PULM Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
PULM Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PULM Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by PULM's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $16,000 Feb 03, 2011 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Oct 06, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Jul 15, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $17,000 Apr 09, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Jan 20, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Nov 09, 2009 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Jul 13, 2009 Issue: Medical/Disease Research/Clinical Labs
  • $16,000 Apr 21, 2009 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Oct 20, 2008 Issue: Budget/Appropriations
  • $20,000 Jul 21, 2008 Issue: Budget/Appropriations
  • $20,000 Apr 21, 2008 Issue: Budget/Appropriations

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Monovalent metal cation dry powders for inhalation May. 09, 2017
  • Patent Title: Cationic dry powders Sep. 06, 2016
  • Patent Title: Dry powder formulations and methods for treating pulmonary diseases Jan. 12, 2016
  • Patent Title: Dry powder formulations and methods for treating pulmonary diseases Jun. 23, 2015
  • Patent Title: Respirably dry powder comprising calcium lactate, sodium chloride and leucine Mar. 31, 2015
  • Patent Title: Respirably dry powder comprising calcium lactate, sodium chloride and leucine Jun. 24, 2014
  • Patent Title: Method and device for decreasing contamination Jan. 14, 2014
  • Patent Title: Formulations decreasing particle exhalation Nov. 26, 2013
  • Patent Title: Formulations decreasing particle exhalation May. 29, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of PULM in WallStreetBets Daily Discussion

PULM News

Recent insights relating to PULM

CNBC Recommendations

Recent picks made for PULM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PULM

PULM Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PULM Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top